RxDoctor Payments Data

Jacqueline Hurd

Family · Atlanta, GANPI 1184246886

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,633 of the $4,247 with a category attached, or 85.5%. 20 manufacturers reported payments, led by AbbVie at 25.5% of the total. Reporting peaked in 2023 at $1,558 and has fallen 92.2% since, to $121 in 2025. Among family clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,247in general payments, 2019–2025

Across 188 payments — averaging $22.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$849
  • Amgen$591
  • Novartis$402
  • Aurinia Pharma U.S., Inc.$190
  • Mallinckrodt Hospital Products Inc.$174
  • plus $959 from 14 others

What the payments were for

  • Consulting fees$59514%
  • Food & beverage$3,63386%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,247 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia →

Other family in Atlanta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →